AZN · Categories · Upgrades

AZN - Analyst upgrades

AstraZeneca PLC (AZN) analyst upgrades - real-time wire coverage filtered to Upgrades only.

Recent Upgrades for AZN

• 494d
  AstraZeneca upgraded by UBS

  UBS upgraded AstraZeneca from Neutral to Buy
• 579d
  AstraZeneca upgraded by UBS

  UBS upgraded AstraZeneca from Sell to Neutral
• 593d
  AstraZeneca upgraded by Deutsche Bank

  Deutsche Bank upgraded AstraZeneca from Sell to Hold
• 797d
  AstraZeneca upgraded by Deutsche Bank

  Deutsche Bank upgraded AstraZeneca from Sell to Hold
• 1001d
  AstraZeneca upgraded by Jefferies with a new price target

  Jefferies upgraded AstraZeneca from Hold to Buy and set a new price target of $80.00 from $66.50 previously
• 1076d
  AstraZeneca upgraded by UBS

  UBS upgraded AstraZeneca from Neutral to Buy
• 1168d
  AstraZeneca upgraded by Morgan Stanley

  Morgan Stanley upgraded AstraZeneca from Equal-Weight to Overweight
• 1393d
  AstraZeneca upgraded by Argus with a new price target

  Argus upgraded AstraZeneca from Hold to Buy and set a new price target of $75.00
• 1592d
  AstraZeneca upgraded by DZ Bank

  DZ Bank upgraded AstraZeneca from Sell to Hold
• 1924d
  AstraZeneca upgraded by Jefferies

  Jefferies upgraded AstraZeneca from Hold to Buy
• 1937d
  AstraZeneca upgraded by UBS Group

  UBS Group upgraded AstraZeneca from Neutral to Buy
• 1943d
  AstraZeneca upgraded by UBS

  UBS upgraded AstraZeneca from Neutral to Buy

Other AZN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings